Measles-containing-vaccine second-dose (MCV2) immunization coverage (%) vs Oncology novel active substance (NAS) launches (cumulative) in China
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%) (annual) and Oncology novel active substance (NAS) launches (cumulative) (multi-month) in China. They are published at different intervals, so each is drawn on its own rather than matched period by period.
Change the pair
Compare different indicators
The series
Over time
China. Measles-containing-vaccine second-dose (MCV2) immunization coverage (%) is published as annual figures and oncology novel active substance (NAS) launches (cumulative) as multi-month ones, so they are drawn on separate charts, clipped to 2015–2020, and no period is matched between them. Read each on its own.
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)
Unit: % · 6 observations
Estimates are listed as such in the table below
Oncology novel active substance (NAS) launches (cumulative)
Unit: count · 2 observations
Shared periods
Side by side
No period lines up: measles-containing-vaccine second-dose (MCV2) immunization coverage (%) is annual and oncology novel active substance (NAS) launches (cumulative) is multi-month. A month and a year are not the same measurement window, so no row pairs them.
Provenance
Where these numbers come from
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)
The percentage of children who have received two doses of measles-containing vaccine (MCV2) in a given year, according to the nationally recommended schedule, based on WHO/UNICEF Estimates of National Immunization Coverage (WUENIC).
6 observations charted in China (of 26 annual records) · source organisations: WHO
Oncology novel active substance (NAS) launches (cumulative)
Total number of oncology novel active substances launched over a stated multi-year period.
2 observations charted in China · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring